Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction: Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

The Original Article was published on 20 February 2017

Nat. Med. 23, 439–449 (2017); published online 20 February 2017; corrected after print 26 July 2017

In the version of this article initially published, the authors inadvertently left out information in the Online Methods section regarding a second injection of AAV8-CFLAR(S1) 7 weeks after the first injection in the monkey experiments to ensure stable expression of CFLAR(S1) in the livers of the monkeys that received the injections. This correction does not change any results or conclusions of the paper. The error has been corrected in the HTML and PDF versions of the article.

Authors

Additional information

The online version of the original article can be found at 10.1038/nm.4290

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, PX., Ji, YX., Zhang, XJ. et al. Correction: Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med 23, 1241 (2017). https://doi.org/10.1038/nm1017-1241b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1017-1241b

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing